References

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study

10.1016/s2215-0366(20)30287-x · 2020 · External reference

10.1176/appi.neuropsych.20230121

10.1176/appi.neuropsych.20230121 · External reference

Psychiatric and neuropsychiatric sequelae of COVID-19 within 2 years: a multinational cohort study

10.1186/s12916-025-03952-z · 2025 · External reference

Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 11128411437 patients

10.1016/s2215-0366(22)00260-7 · 2022 · External reference

Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study

10.1016/s0140-6736(22)01214-4 · 2022 · External reference

Patients with neurological or psychiatric complications of COVID-19 have worse long-term functional outcomes: COVID-CNS—A multicentre case–control study

10.1038/s41598-024-80833-0 · 2025 · External reference

10.1016/j.bbi.2020.04.031

10.1016/j.bbi.2020.04.031 · External reference

Neuropsychiatric aspects of COVID-19 pandemic: A selective review

10.1016/j.ajp.2020.102188 · 2020 · External reference

10.1038/s41579-022-00846-2

10.1038/s41579-022-00846-2 · External reference

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2

10.1016/j.stemcr.2021.12.011 · 2022 · External reference

10.1016/j.chom.2024.11.007

10.1016/j.chom.2024.11.007 · External reference

10.1038/s41467-023-42320-4

10.1038/s41467-023-42320-4 · External reference

Risk Factors Associated With Post−COVID-19 Condition

10.1001/jamainternmed.2023.0750 · 2023 · External reference

10.1038/s41591-024-03309-8

10.1038/s41591-024-03309-8 · External reference

Sex and age affect acute and persisting COVID-19 illness

10.1038/s41598-023-33150-x · 2023 · External reference

10.7150/ijbs.75056

10.7150/ijbs.75056 · External reference

10.1038/s41586-022-04569-53

10.1038/s41586-022-04569-53 · External reference

Functional brain alterations in COVID-19 patients using resting-state fMRI: a systematic review

10.1007/s11682-024-00935-1 · 2024 · External reference

10.1093/ijnp/pyy100

10.1093/ijnp/pyy100 · External reference

Regional Homogeneity

10.1177/1073858415595004 · 2016 · External reference

Altered brain regional homogeneity is associated with depressive symptoms in COVID-19

10.1016/j.jad.2022.06.061 · 2022 · External reference

Altered intrinsic brain activity and functional connectivity in COVID-19 hospitalized patients at 6-month follow-up

10.1186/s12879-023-08331-8 · 2023 · External reference

Brain abnormalities in survivors of COVID-19 after 2-year recovery: a functional MRI study

2024 · External reference

10.15557/pimr.2020.0004

10.15557/pimr.2020.0004 · External reference

10.1038/s41467-023-42320-4

10.1038/s41467-023-42320-4 · External reference

10.1371/journal.pone.0273704

10.1371/journal.pone.0273704 · External reference

10.1016/j.neuroimage.2003.12.030

10.1016/j.neuroimage.2003.12.030 · External reference

10.1136/bmj.l1476

10.1136/bmj.l1476 · External reference

10.1097/01.mlr.0000093487.78664.3c

10.1097/01.mlr.0000093487.78664.3c · External reference

10.1097/mlr.0b013e318160d093

10.1097/mlr.0b013e318160d093 · External reference

Computerised cognitive assessment in patients with traumatic brain injury: an observational study of feasibility and sensitivity relative to established clinical scales

10.1016/j.eclinm.2023.101980 · 2023 · External reference

The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort study

10.1016/j.eclinm.2023.102086 · 2023 · External reference

Cognitive deficits in people who have recovered from COVID-19

10.1016/j.eclinm.2021.101044 · 2021 · External reference

Multivariate profile and acute-phase correlates of cognitive deficits in a COVID-19 hospitalised cohort

10.1016/j.eclinm.2022.101417 · 2022 · External reference